A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200
Clinical trial NCT05238337 · COMPLETED
Trial details
- NCT number
- NCT05238337
- Sponsor
- Pyramid Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2022-03-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.